KELLANE HOWELL: Open Payments
NPI 1912372905 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 41 payments from 8 companies in 2025. Trend: 2023 $1,269 · 2024 $1,283 · 2025 $1,096
Food & beverage: $1,096
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $267 |
| E.R. Squibb & Sons, L.L.C. | 11 | $244 |
| ABBVIE INC. | 10 | $215 |
| Otsuka America Pharmaceutical, Inc. | 5 | $136 |
| Neurocrine BioSciences, Inc. | 3 | $108 |
| Vanda Pharmaceuticals Inc. | 2 | $87 |
| Alkermes, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: COBENFY, VRAYLAR, UZEDY, REXULTI, AUSTEDO XR, INGREZZA, FANAPT, HETLIOZ.
Industry payments across FL — which companies pay providers there.
